89 related articles for article (PubMed ID: 4593270)
1. Immunological and haematological investigations on patients with adverse reactions during treatment with RMP plus INH once-weekly.
Herrmann H; Eule H
Scand J Respir Dis Suppl; 1973; 84():87-93. PubMed ID: 4593270
[No Abstract] [Full Text] [Related]
2. Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment.
Eule H; Kärnbach E; Kaluza P; Herrmann H
Scand J Respir Dis Suppl; 1973; 84():153-9. PubMed ID: 4593264
[No Abstract] [Full Text] [Related]
3. Haematological changes during intermittent treatment with rifampicin.
Wislawska-Orlowska B; Pniewski T
Scand J Respir Dis Suppl; 1973; 84():94-7. PubMed ID: 4522080
[No Abstract] [Full Text] [Related]
4. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
Nitti V
Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
[No Abstract] [Full Text] [Related]
5. Rifampicin-dependent antibodies in twice-weekly treated patients.
Algeorge G; Rudescu D; Alexandrescu D
Scand J Respir Dis Suppl; 1973; 84():98-101. PubMed ID: 4522081
[No Abstract] [Full Text] [Related]
6. Proceedings of the Workshop on Intermittent Drug Therapy and Immunological Implications in Antituberculous Treatment with Rifampicin. Oct. 2-3, 1972 Stockholm. Organized by The Department of Thoracic Medicine, Karolinska Sjukhuset.
Scand J Respir Dis Suppl; 1973; 84():1-193. PubMed ID: 4593267
[No Abstract] [Full Text] [Related]
7. Side effects observed during intermittent rifampicin therapy.
Stradling P
Scand J Respir Dis Suppl; 1973; 84():129-31. PubMed ID: 4522066
[No Abstract] [Full Text] [Related]
8. Fibrinogen and antithrombin III blood levels fluctuations during isoniazid or isoniazid plus rifampicin administration.
Farmakis M; Travlou O; Aroni S; Fertakis A
Arzneimittelforschung; 1992 Aug; 42(8):1041-4. PubMed ID: 1418078
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
[No Abstract] [Full Text] [Related]
10. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
Eule H; Werner E; Winsel K; Iwainsky H
Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
[No Abstract] [Full Text] [Related]
11. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
[TBL] [Abstract][Full Text] [Related]
12. Clinical aspects of side effects on intermittent rifampicin regimen.
Zierski M
Scand J Respir Dis Suppl; 1973; 84():166-73. PubMed ID: 4522072
[No Abstract] [Full Text] [Related]
13. Rifampicin-dependent antibodies during intermittent treatment.
Virgilio R
Scand J Respir Dis Suppl; 1973; 84():83-6. PubMed ID: 4593269
[No Abstract] [Full Text] [Related]
14. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
Anastasatu C; Bercea O; Barcan F; Stinghe R; Dinulică E; Marcovici M; Cristea M; Cărpinişan L; Gheorghiu M; Iancovici O; Ghinescu S
Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931
[No Abstract] [Full Text] [Related]
15. Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002.
LoBue PA; Moser KS
Int J Tuberc Lung Dis; 2005 May; 9(5):501-6. PubMed ID: 15875920
[TBL] [Abstract][Full Text] [Related]
16. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
Konno K; Oizumi K; Yamada S; Ogata K; Sato M
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
[No Abstract] [Full Text] [Related]
17. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
[No Abstract] [Full Text] [Related]
18. [Is the combination of INH and RFP always bactericidal? An observation in programme condition--report of the B series of 20th Controlled Trial of Chemotherapy (author's transl)].
Kekkaku; 1980 Apr; 55(4):207-14. PubMed ID: 6993746
[No Abstract] [Full Text] [Related]
19. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
[No Abstract] [Full Text] [Related]
20. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
Girling DJ
Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
